Skip to main content
Clinical Trials/EUCTR2009-012758-18-DE
EUCTR2009-012758-18-DE
Active, not recruiting
Not Applicable

A randomized multi-center treatment study (COALL 08-09) to improve the survival of children with acute lymphoblastic leukemia on behalf of the German Society of Pediatric Hematology and Oncology - COALL 08-09

niversitätsklinikum Hamburg-Eppendorf0 sitesJanuary 4, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
acute lymphoblastic leukemia in children and adolescents 1 to = 18 years of age
Sponsor
niversitätsklinikum Hamburg-Eppendorf
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 4, 2010
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversitätsklinikum Hamburg-Eppendorf

Eligibility Criteria

Inclusion Criteria

  • Children and adolescents aged 1 up to \= 18 years with a confirmed diagnosis of acute B\-precursor or T\-cell leukemia
  • Parent’s or legal guardian’s written informed consent and child’s assent
  • Phase II: high risk ALL defined by MRD load. B\-precursor ALL at day 29 \= 10\-4, T\-ALL at day 43 \= 10\-3
  • Phase III: MRD positive B\-progenitor ALL and T\-ALL with MRD \= 10\-3 at day 29
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • ALL diagnosed as second malignancy
  • Cytostatical pre\-treatment for more than 1 week
  • Prior severe disease that prohibit treatment according to the protocol
  • Patients with translocation t(9/22\)
  • Pregnant or breastfeeding adolescents

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
A study comparing the effect of chemotherapy with the effect of chemotherapy plus local removal of metastases for patients with cancer of the large bowel which has spread to multiple organs.multi-organ metastatic colorectal cancerMedDRA version: 21.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2011-005003-32-NLVU University Medical Center, Department of Medical Oncology478
Recruiting
Not Applicable
A randomized multicenter clinical trial for patients with multi-organ colorectal cancer metastases comparing the combination of chemotherapy and maximal tumor debulking versus chemotherapy alone.
NL-OMON54652Radboud Universitair Medisch Centrum408
Active, not recruiting
Not Applicable
A randomised multicenter clinical trial for patients with multi-organ, colorectal cancer metastases comparing the combination of chemotherapy and removing as many visible tumors as possible by surgery or other means versus chemotherapy aloneMulti-organ, colorectal cancer metastasesCancer
ISRCTN15067672Radboud University Medical Centre Nijmegen (Netherlands)478
Completed
Not Applicable
The evaluation of the Chinese iSupport for dementia program for caregivers in Australia and Greater China
ACTRN12621000276853ational Foundation for Australia-China Relations204
Completed
Not Applicable
Autoinflation for Aboriginal and Torres Strait Islander Children with OME (middle ear infection)Otitis Media with EffusionHealth of Aboriginal ChildrenEar - Other ear disordersInfection - Other infectious diseases
ACTRN12617001652369Western Sydney University150